Callan Family Office’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
10,254
+113
+1% +$16.5K 0.04% 426
2026
Q1
$1.25M Buy
10,141
+1,721
+20% +$226K 0.03% 499
2025
Q4
$1.1M Buy
8,420
+5,481
+186% +$643K 0.02% 521
2025
Q3
$279K Buy
2,939
+124
+4% +$12.3K 0.01% 733
2025
Q2
$269K Buy
+2,815
New +$228K 0.01% 803

Other funds holding ILMN

Callan Family Office's ILMN Position: Q2 2026 in Review

Callan Family Office increased its Illumina (ILMN) stake by 1.1% in Q2 2026, buying an estimated $16.5K and bringing the position to 10,254 shares worth $1.8M. The position accounts for 0.04% of the portfolio, ranked #426.

Callan Family Office first reported a position in ILMN in Q2 2025 and has held it in 5 quarters since. 939 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Callan Family Office held 10,254 shares of Illumina worth $1.8M as of Q2 2026.
  • Callan Family Office bought 113 Illumina shares in Q2 2026, an estimated $16.5K.
  • Illumina made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #426 holding.
  • Callan Family Office first reported a position in Illumina in Q2 2025 and has held it in 5 quarters since.
  • 939 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.